Identifikation und immunologische Charakterisierung von MHC ...

6. Literaturverzeichnis
Lode, HN, Xiang, R., Pertl, U., Forster, E., Schoenberger, SP, Gillies, SD and
Reisfeld, RA (2000). Melanoma immunotherapy by targeted IL-2 depends on
CD4(+) T-cell help mediated by CD40/CD40L interaction. J. Clin. Invest. 105:
1623-1630.
Lu, J. and Celis, E. (2000). Use of two predictive algorithms of the world wide
web for the identification of tumor-reactive T-cell epitopes. Cancer Res. 60:
5223-5227.
Ludviksson, BR, Seegers, D., Resnick, AS and Strober, W. (2000). The effect of
TGF-beta1 on immune response of naïve versus memory CD4+ Th1/Th2 T
cells. Eur. J. Immunol. 30: 2101-2111.
Lutz, PG, Moog-Lutz, C., Coumau-Gatbois, E., Kobari, L., Di Gioia, Y., Cayre,
YE (2000). Myeloblastin is a granulocyte colony-stimulating factor-responsive
gene conferring factor-independent growth to hematopoietic cells. Proc. Natl.
Acad. Sci. U S A 97(4): 1601-1606.
Lutz, PG, Houzel-Chavarel, A., Moog-Lutz, C. and Cayre, YE (2001).
Myeloblastinis an Myb target gene: mechanisms of regulation in myeloid
leukemia cells growth-arrested by retinoic acid. Blood 97: 2449-2456.
Mackensen, A., Herbst, B., Chen, JL, Kohler, G., Noppen, C., Herr, W.,
Spagnoli, GC, Cerundolo, V. and Lindemann, A. (2000). Phase I study in
melanoma patients of a vaccine with peptide-pulsed dendritic cells generated
in vitro from CD34(+) hematopoietic progenitor cells. Int. J. Cancer 86: 385-392.
Mahotka, C., Wenzel, M., Springer, E., Gabbert, HE and Gerharz, CD (1999).
Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis
111